Patents by Inventor Mark L. Gonzalgo

Mark L. Gonzalgo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer diagnostic method based upon DNA methylation differences
    Patent number: 7662563
    Abstract: There is disclosed a cancer diagnostic method based upon DNA methylation differences at specific CpG sites. Specifically, the inventive method provides for a bisulfite treatment of DNA, followed by methylation-sensitive single nucleotide primer extension (Ms-SNuPE), for determination of strand-specific methylation status at cytosine residues.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: February 16, 2010
    Assignee: University of Southern California
    Inventors: Mark L. Gonzalgo, Peter A. Jones, Gangning Liang
  • Cancer diagnostic method based upon DNA methylation differences
    Patent number: 7037650
    Abstract: There is disclosed a cancer diagnostic method based upon DNA methylation differences at specific CpG sites. Specifically, the inventive method provides for a bisulfite treatment of DNA, followed by methylation-sensitive single nucleotide primer extension (Ms-SNuPE), for determination of strand-specific methylation status at cytosine residues.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: May 2, 2006
    Assignee: University of Southern California
    Inventors: Mark L. Gonzalgo, Peter A. Jones, Gangning Liang
  • Cancer diagnostic method based upon DNA methylation differences
    Patent number: 6811982
    Abstract: There is disclosed a cancer diagnostic method based upon DNA methylation differences at specific CpG sites. Specifically, the inventive method provides for a bisulfite treatment of DNA, followed by methylation-sensitive single nucleotide primer extension (Ms-SNuPE), for determination of strand-specific methylation status at cytosine residues.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: November 2, 2004
    Assignee: University of Southern California
    Inventors: Mark L. Gonzalgo, Peter A. Jones, Gangning Liang
  • Cancer diagnostic method based upon DNA methylation differences
    Publication number: 20030211473
    Abstract: There is disclosed a cancer diagnostic method based upon DNA methylation differences at specific CpG sites. Specifically, the inventive method provides for a bisulfite treatment of DNA, followed by methylation-sensitive single nucleotide primer extension (Ms-SNuPE), for determination of strand-specific methylation status at cytosine residues.
    Type: Application
    Filed: June 22, 2001
    Publication date: November 13, 2003
    Inventors: Mark L. Gonzalgo, Peter A. Jones, Gangning Liang
  • Cancer diagnostic method based upon DNA methylation differences
    Publication number: 20020177154
    Abstract: There is disclosed a cancer diagnostic method based upon DNA methylation differences at specific CpG sites. Specifically, the inventive method provides for a bisulfite treatment of DNA, followed by methylation-sensitive single nucleotide primer extension (Ms-SNuPE), for determination of strand-specific methylation status at cytosine residues.
    Type: Application
    Filed: March 28, 2002
    Publication date: November 28, 2002
    Inventors: Mark L. Gonzalgo, Peter A. Jones, Gangning Liang
  • Cancer diagnostic method based upon DNA methylation differences
    Patent number: 6251594
    Abstract: There is disclosed a cancer diagnostic method based upon DNA methylation differences at specific CpG sites. Specifically, the inventive method provides for a bisulfite treatment of DNA, followed by methylation-sensitive single nucleotide primer extension (Ms-SNuPE), for determination of strand-specific methylation status at cytosine residues.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: June 26, 2001
    Assignee: USC/Norris Comprehensive Cancer Ctr.
    Inventors: Mark L. Gonzalgo, Peter A. Jones, Gangning Liang